Keros Therapeutics, Inc. Profile Avatar - Palmy Investing

Keros Therapeutics, Inc.

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. T…

Biotechnology
US, Lexington [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Keros Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Keros Therapeutics, Inc. can't present revenue by segment

End of KROS's Analysis
CIK: 1664710 CUSIP: 492327101 ISIN: US4923271013 LEI: - UEI: -
Secondary Listings
KROS has no secondary listings inside our databases.